Propanc Biopharma, Inc., a development-stage biopharmaceutical healthcare company, engages in the development of cancer treatments for patients with pancreatic, ovarian, and colorectal cancers in Australia. Its lead product candidate is PRP...
Leadership
James Nathanielsz
CEO & Executive Chairman
Jeannine Zimmerman
Chief Financial Officer
Klaus Kutz M.D.
Chief Medical Officer & Member of Scientific Advisory Board
